Monthly Essentials May’16: Dementia


  • Pavankumar Kamat
  • Global Monthly Essentials
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.
The 3 essential articles on Dementia this month, selected from 758 peer-reviewed articles:

Ideal cardiovascular health index predicts dementia risk
Inappropriate prescribing among community dwellers with dementia
H.pylori infection and dementia

Ideal cardiovascular health index predicts dementia risk

Source: Stroke                                                     

Takeaway

  • Ideal cardiovascular health (CVH) index predicts risk for dementia and cognitive decline as well as risk for cerebrovascular disease.

Key results

  • Recent ideal CVH was associated with lower risk of vascular dementia (HR, 0.49; 95% CI, 0.30-0.81), frontal brain atrophy (P=.003), decline in visual memory and reasoning (P<.05), and stroke (HR, 0.80; 95% CI, 0.67-0.95).
  • Remote ideal CVH (6.9 y earlier) predicted vascular dementia, whole-brain atrophy, cognitive decline, and stroke and was associated with incidence of all-cause dementia (HR, 0.80; 95% CI, 0.67-0.97) and Alzheimer disease (HR, 0.79; 95% CI, 0.64-0.98).

Study design

  • 2750 Framingham Heart Study Offspring cohort participants (mean age, 62±9 y; 45% men), free of stroke and dementia at baseline, underwent measurement of 10-y risks of incident stroke and dementia, and ≈7 y risks of cognitive decline and MRI brain atrophy.
  • Ideal CVH determination was 0-7-points (1 point each for nonsmoking, ideal body mass index, regular physical activity, healthy diet, optimum blood pressure, cholesterol, and fasting glucose).

Why this matters

  • Following ideal CVH factors and behaviors, especially in midlife, may protect against dementia as well as cerebrovascular disease.

PubMed Abstract

Inappropriate prescribing among community dwellers with dementia

Source: J Alzheimers Dis                                                    

Takeaway

  • Potentially inappropriate prescribing (PIP) is highly prevalent among community dwellers with dementia.

Key results

  • Polypharmacy, defined as use of 4 or more repeat medications from different drug groups, occurred in 81.5% of the patients, and PIP in 64.4% (95% CI, 63.2%-65.5%).
  • The most prevalent PIP was use of anticholinergic/antimuscarinic medications (25.2%; 95% CI, 24.2%-26.2%).
  • Polypharmacy and female sex were associated with PIP (OR, 7.6 [95% CI, 6.6-8.7] and OR, 1.3 [95% CI, 1.2-1.4]), on the basis of multivariable analyses.
  • After adjustments for sex and polypharmacy, PIP was not associated with age, on the basis of logistic regression.

Study design

  • 6826 patients from the Northern Ireland Enhanced Prescribing Database were prescribed a medication indicated for dementia management during 2013.
  • Researchers applied a subset of 36 indicators from the Screening Tool of Older Persons Potentially Inappropriate Prescriptions criteria to the dataset.

Why this matters

  • Clinicians should be targeted for interventions to reduce PIP, particularly regarding polypharmacy and certain therapeutic categories.

PubMed Abstract

H.pylori infection and dementia

Source: J Alzheimers Dis                                                       

Takeaway

  • Helicobacter pylori (H. pylori) infection is associated with dementia risk.

Key results

  • Of 13 studies addressing cognition and/or dementia in association with H. pylori infection, 7 were included in the meta-analysis.
  • H. pylori infection was significantly positively associated with dementia (pooled OR, 1.71; (95% CI, 1.17-2.49; P=.01; no significant evidence of publication bias).

Study design

  • A Search on OVID-Medline, Institute of Scientific Information Web of Science, and EMBASE identified 260 studies in which the exposure variable was H. pylori infection and the outcome was incident dementia.

Why this matters

  • The underlying biological mechanisms and the effect of treating H. pylori on dementia risk and progression are still unknown. 

PubMed Abstract